← Back to Dashboard

CIPLA Cipla Ltd. — Smart-Money Activity, F&O Buildup & Bulk Deals

Sector: Healthcare · Nifty 50 Weight: 0.66%
₹ 1,301.00
-0.44%
1-year price · range ₹1,192–₹1,639

Live setups screens CIPLA is on right now — tap to see every stock matching

Smart Money Verdict synthesis of derivatives, deals, and promoter files

Derivatives signal Short Buildup
Short sellers are loading fresh positions (OI up +1.0%) on price weakness (-2.4%).

Analysis what the data is telling us about CIPLA

In the last completed session, Cipla Ltd. closed -2.40% with futures open interest moving +1.0%. That combination — price falling while OI builds — is classified as Short Buildup. Fresh short positions are being added on weakness, which historically prefaces further downside until shorts are forced to cover. The stock's option PCR sits at 0.64, indicating heavy call-side writing — option dealers see resistance overhead. Max-pain strike at ₹1,350 sits 3.8% above the current price, a mild magnet near expiry.

There have been no notable bulk or block deals from FIIs, mutual funds, or insurance companies in Cipla Ltd. over the last 30 sessions.

Putting it together, the smart-money picture for Cipla Ltd. points to a softer setup at the next open. The next scheduled earnings report is on 2026-10-27, with the consensus EPS estimate at ₹11.595. Earnings days routinely override positioning signals — keep an eye on the calendar.

F&O Positioning EOD derivatives setup

Buildup Class
Short Buildup
bias: bearish
Futures OI
10,045,300
+102425 (+1.0%)
Option PCR (OI)
0.64
heavy call writing
Max Pain Strike
₹ 1,350
writer loss minimized strike

Quote Details key metrics & weights

Previous Close
₹ 1,306.80
yesterday's EOD close
Index Contribution
-0.003 pp
contribution to Nifty
Traded Volume
653,621
live shares traded today
Upcoming Earnings
2026-10-27
EPS est: 11.595

Technical Snapshot as of 2026-10-09 close · from 400 sessions of price history

RSI (14)
26.2
oversold
52-Week High
₹ 1,673.00
-22.2% from high
52-Week Low
₹ 1,165.70
+11.6% above low
200-DMA
₹ 1,373.47
-5.3% · below trend
50-DMA
₹ 1,400.18
-7.1% from 50-DMA
1-Year Return
-14.0%
1M -5.3%

Key Fundamentals headline ratios · Healthcare

P/E (TTM)
31.2
price / earnings
P/B
3.0
price / book
ROE
—
return on equity
Market Cap
₹ 105,104 Cr
total market value
Dividend Yield
1.00%
trailing yield
EPS (TTM)
₹ 41.70
earnings per share

Fundamental ratios sourced from public market data, refreshed periodically; verify against company filings before relying on them.

Institutional Deals last 30 sessions (bulk & block)

No institutional bulk or block deals recorded for this stock in the last 30 sessions.

Insider & Promoter Filings last 60 days

No insider disclosures filed for this stock in the last 60 days.

Option Chain Ladder nearest expiry 2026-10-27 · spot 1,307 · EOD 2026-10-08

Option writers expect range between 1,220 and 1,450 — +11.0% upside, -6.6% downside.
upside-skewed
Call OI (writers) Strike Put OI (writers)
2,125
IV 82% Δ 0.64 θ -2.6 ν 1
1250
126,225 +15k
IV 28% Δ -0.21 θ -0.6 ν 1
425
IV 93% Δ 0.62 θ -3.0 ν 1
1260
97,325 +6k
IV 27% Δ -0.24 θ -0.6 ν 1
2,550 +2k
IV 19% Δ 0.78 θ -0.6 ν 1
1270
66,300 -13k
IV 28% Δ -0.29 θ -0.7 ν 1
3,400 +2k
IV 22% Δ 0.69 θ -0.8 ν 1
1280
95,200 +18k
IV 28% Δ -0.34 θ -0.8 ν 1
16,575 +16k
IV 22% Δ 0.64 θ -0.8 ν 1
1290
42,925 +8k
IV 28% Δ -0.39 θ -0.8 ν 1
77,775 +65k
IV 22% Δ 0.58 θ -0.8 ν 1
1300
158,525 +42k
IV 28% Δ -0.43 θ -0.8 ν 1
49,300 +39k
IV 23% Δ 0.52 θ -0.9 ν 1
1310
125,800 +49k
IV 28% Δ -0.48 θ -0.8 ν 1
85,425 +15k
IV 23% Δ 0.46 θ -0.8 ν 1
1320
117,725 -48k
IV 29% Δ -0.53 θ -0.8 ν 1
130,050 +28k
IV 23% Δ 0.40 θ -0.8 ν 1
1330
116,875 -14k
IV 30% Δ -0.57 θ -0.8 ν 1
324,700 +74k
IV 24% Δ 0.35 θ -0.8 ν 1
1340
381,225 -11k
IV 28% Δ -0.62 θ -0.7 ν 1
349,775 +0k
IV 24% Δ 0.30 θ -0.7 ν 1
1350 MP
225,250 -6k
IV 29% Δ -0.66 θ -0.7 ν 1
168,725 +2k
IV 24% Δ 0.25 θ -0.7 ν 1
1360
73,950 -3k
IV 33% Δ -0.68 θ -0.8 ν 1
119,425 +3k
IV 24% Δ 0.22 θ -0.6 ν 1
1370
48,025 -2k
IV 29% Δ -0.74 θ -0.6 ν 1

Chain Interpretation

Spot Underlying 1,306.80
Key Resistance (R) 1,450
Key Support (S) 1,220
Max Pain Strike (MP) 1,350
Concentrations of Option open interest show strong barrier levels. Option writers defend these levels, especially heading into monthly derivatives expiry.

Strategy Builder multi-leg payoff for CIPLA options · 2026-10-27 expiry

Underlying: CIPLA · Spot: ₹ 1,306.80 · Expiry: 2026-10-27 · Lot: 425

Legs

Side
Type
Strike
Qty
Premium
Net premium—
Max profit—
Max loss—
Breakevens—
Position Delta—
Position Theta/day—
Position Vega/1% IV—

Payoff at expiry

Latest News recent coverage from Reuters, Simply Wall St, MT Newswires and others

No recent news articles found for this stock.

CIPLA — frequently asked questions

What is the Cipla Ltd. share price today?

CIPLA is trading at ₹1,301.00 (-0.44% vs previous close), per the latest update on this page.

What is the P/E ratio of Cipla Ltd.?

CIPLA (Cipla Ltd.) has a trailing twelve-month P/E ratio of 31.2.

What is the market cap of Cipla Ltd.?

CIPLA has a market capitalisation of approximately ₹105,104 crore.

Is CIPLA near its 52-week high?

CIPLA is trading -22.2% from its 52-week high of ₹1,673.00 as of 2026-10-09.

What is the RSI of CIPLA?

The 14-day RSI of CIPLA is 26.2, which is considered oversold.

Is CIPLA above its 200-day moving average?

CIPLA is trading below its 200-DMA of ₹1,373.47 (-5.3% away).

What is the F&O buildup in CIPLA?

The latest end-of-day derivatives data classifies CIPLA as Short Buildup (bias: bearish), based on the day's combined price and open-interest change.

What is the max pain and PCR for CIPLA options?

CIPLA's option-chain max pain strike is ₹1,350 and its put-call ratio (OI) is 0.64, from the latest end-of-day option chain.

Are FIIs or big investors buying CIPLA?

Strota tracks every bulk and block deal in CIPLA with named buyers and sellers, plus promoter and insider filings — the tables on this page list the most recent institutional activity as disclosed to the exchanges.